Updated:
GlycoNet
GlycoNet is a pan-Canadian research network funded by the Networks of Centres of Excellence. It focuses on glycomics to address health issues and improve...
GlycoNet
GlycoNet is a pan-Canadian research network funded by the Networks of Centres of Excellence. It focuses on glycomics to address health issues and improve Canadians' quality of life. GlycoNet has made 5 investments, including a 2022 investment in Zucara, and has 1 portfolio exit, PanTHERA CryoSolutions, in 2025.
General information
Firm type
Other
Location
Region
North America
Country
Canada
City
Edmonton
Corporate office
Edmonton, Alberta, Canada
Sector focus
Frequently asked questions
What is GlycoNet's primary investment focus?
GlycoNet specializes in glycomics and glycobiology, targeting early-stage biotechnology and life sciences opportunities centered on carbohydrate structures. This includes drug discovery, vaccine development, and diagnostic tools (per public record).
Where is GlycoNet based?
GlycoNet is headquartered in Edmonton, Alberta, Canada. No additional office locations have been disclosed.
Does GlycoNet publicly disclose its assets under management?
GlycoNet has not publicly disclosed its AUM or deployment figures. Industry estimates are not available.
Who controls investment decisions at GlycoNet?
GlycoNet has not publicly named its principals, leadership, or investment committee members. The firm's governance structure is not documented in public sources.
How does GlycoNet differentiate itself from other life sciences investors?
GlycoNet's focus on glycomics sets it apart from more common biotech investment themes such as gene therapy or immunotherapy. This specialized mandate may offer access to niche research assets and academic partnerships.
Does GlycoNet partner with academic institutions?
Yes, GlycoNet's activities suggest collaboration with academic researchers in glycomics, particularly within Canada and potentially internationally. Specific institutions have not been named in public sources.
What is the wealth origin behind GlycoNet?
The wealth origin of GlycoNet is not publicly disclosed. No family or individual has been associated with the entity in public records.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: